11 July 2019 - The pharmaceutical market has undergone radical changes, including markedly increased prices for rare-disease drugs. ...
9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...
18 January 2019 - "We are in uncharted territory. This is a watershed moment in the life of this agency," he ...
10 January 2018 - According to US FDA regulations, the regulatory agency may refuse to file a new drug application ...
25 September 2017 - Since we launched our Patient Preference Initiative as part of our medical device regulatory decision-making process ...
7 September 2017 - We’re at a moment of extraordinary opportunity to improve the public health. New innovations are giving us ...
22 August 2017 - Evidence linking interventions with health outcomes is the basis for good health care decision making. ...
2 August 2017 - A core principle of good public health practice is to base all policy decisions on the highest-quality ...
13 July 2017 - Evidence linking interventions with health outcomes is the basis for good health care decision making. ...
13 March 2017 - Not likely, says F. Perry Wilson, MD. ...
13 December 2016 - In September 2016, the US FDA approved eteplirsen (Exondys 51), a new drug for Duchenne muscular ...
16 November 2016 - Now that pharma has prevailed in free-speech legal battles concerning off-label marketing, it’s pushing the FDA ...
15 October 2016 - Approving an unproven drug sets a worrying precedent. ...
18 July 2016 - This study uses US FDA data to identify approved generic drugs manufactured between September 30, 1984, and ...
24 February 2016 - Today the U.S. Senate voted in support of the confirmation of Dr. Robert Califf, M.D. to ...